Quantitative Biopharmaceutics: Use of Modelling and Simulation to Inform API and Formulation Decisions

3/14/2018 13:40 - 14:15

  • Case studies of use of absorption modelling for early phase API/formulation selection
  • Case studies of use of modelling for bioequivalence simulations
  • Addressing emerging gaps – case studies on simulation of amorphous solid dispersions and nanoparticles

Filippos Kesisoglou, Senior Principal Scientist, Biopharmaceutics and Pharmaceutical Sciences, MSD